Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Analysis of response of severe eosinophilic asthmatic patients to benralizumab.
Miralles-López JC, Andújar-Espinosa R, Bravo-Gutiérrez FJ, Castilla-Martínez M, Flores-Martín I, Alemany-Francés ML, Pajarón-Fernández MJ, Mora-González A, Cabrejos-Perotti S, El-Molaka Z, Meseguer-Arce J, Avilés-Inglés MJ, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR Group. Miralles-López JC, et al. Among authors: castilla martinez m. Allergol Immunopathol (Madr). 2022 Nov 1;50(6):163-168. doi: 10.15586/aei.v50i6.704. eCollection 2022. Allergol Immunopathol (Madr). 2022. PMID: 36335460
Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice.
Miralles López JC, Andújar-Espinosa R, Bravo-Gutiérrez FJ, Castilla-Martínez M, Flores-Martín I, Alemany-Francés ML, Pajarón-Fernández MJ, Mora González A, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR GROUP. Miralles López JC, et al. Among authors: castilla martinez m. J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):220-223. doi: 10.18176/jiaci.0793. Epub 2022 Feb 15. J Investig Allergol Clin Immunol. 2022. PMID: 35166673 Free article. No abstract available.
Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study.
Castilla-Martínez M, Andújar-Espinosa R, Flores-Martín I, Reyes Cotes MH, Cabrejos-Perotti S, Miralles-López JC, Carbonell-Martínez A, Bravo-Gutiérrez FJ, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR GROUP. Castilla-Martínez M, et al. J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0872. Online ahead of print. J Investig Allergol Clin Immunol. 2022. PMID: 36420744 Free article. No abstract available.
Is COVID-19 a turning point for the health workforce?
Aith F, Castilla Martínez M, Cho M, Dussault G, Harris M, Padilla M, Murphy GT, Tomlin P, Valderas JM. Aith F, et al. Among authors: castilla martinez m. Rev Panam Salud Publica. 2020 Sep 16;44:e102. doi: 10.26633/RPSP.2020.102. eCollection 2020. Rev Panam Salud Publica. 2020. PMID: 32952532 Free PMC article. No abstract available.
What's New in the 2022 Consensus for Severe Asthma in Adults.
Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiña-Tordera M, Soto-Campos G. Alvarez-Gutiérrez FJ, et al. Among authors: castilla martinez m. Arch Bronconeumol. 2023 Mar;59(3):190-192. doi: 10.1016/j.arbres.2022.09.012. Epub 2022 Sep 28. Arch Bronconeumol. 2023. PMID: 36243640 English, Spanish. No abstract available.